The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,328 records6 sources
Showing 1–24 of 11,328
TrialPsilocybin

Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation

ClinicalTrials.gov2026
TrialPsilocybin

Psilocybin Therapy for Methamphetamine Use Disorder and HIV

ClinicalTrials.gov2026
TrialKetamine

Effect of Ketamine-Propofol Total Intravenous Anesthesia Versus Sevoflurane-Based Anesthesia on Postoperative Vomiting in Children Undergoing Strabismus Surgery

ClinicalTrials.gov2026
TrialPsilocybin

Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study

ClinicalTrials.gov2026
TrialKetamine

Efficacy of Intravenous Midazolam-Ketamine Combination Versus Placebo for Prevention of Post-Spinal Shivering in Elective Cesarean Section

ClinicalTrials.gov2026
ArticleKetamine

Management of Neuropathic Pain in Complex Regional Pain Syndrome: A Comprehensive Review.

Donati D, D'Auria L, Ricci V +3

Europe PMC2026
ArticleMDMA

A Quantitative Analysis of Street-Level Drugs Seized in New South Wales, Australia: Purity, Dose and Adulterants.

Smith JL, Harvey CA, Ewers CJ +4

Europe PMC2026
TrialMDMA

MDMA-AT for PTSD in Young Adults With Childhood Trauma

ClinicalTrials.gov2026
TrialPsilocybin

MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial

ClinicalTrials.gov2026
TrialKetamine

Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar Depression

ClinicalTrials.gov2026
TrialPsilocybin

Psilocybin Efficacy With or Without Pimavanserin Pretreatment

ClinicalTrials.gov2026
TrialKetamine

Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers

ClinicalTrials.gov2026
TrialPsilocybin

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

ClinicalTrials.gov2026
TrialKetamine

KetAmine and Recovery After Mechanical VentilAtion ( KARMA )

ClinicalTrials.gov2026
TrialKetamine

Morphine or Ketamine for Analgesia

ClinicalTrials.gov2026
ArticleKetamine

Correction: Sustained abstinence in severe ketamine use disorder following ibogaine treatment case report

Pérez Rosal S, Faber S, Backmund M

Europe PMC2026
ArticleKetamine

Safety, efficacy, and opioid-sparing effects of ketamine for analgesia in traumatic chest injury and rib fractures: a systematic review and meta-analysis

Zhang K, Zheng J, Zhang Y +3

Europe PMC2026
PreprintLSD

Serotonergic psychedelics delay resting state neurovascular coupling dynamics

Mundel L, Medel V, Timmermann C +9

Europe PMC2026
PreprintPsilocybin

Context Shapes Alpha-Band Electrophysiological Signatures Under Psilocybin

Dhanawansa V, Stoliker D, Novelli L +3

Europe PMC2026
PreprintPsychedelics

Contexts, Risks, and Affordances among Autistic Adults Using Psychedelics for Therapeutic Purposes: A Naturalistic, Mixed-Methods Study

Sam A, De Foe A, Rabba AS +4

Europe PMC2026
ArticlePsilocybin

Stroboscopic light stimulation as a controllable probe of the psilocybin state: a mechanistic framework and a falsifiable prediction

Żełabowski K, Wieczorek T, Hamed A

Europe PMC2026
ArticlePsychedelics

Studying the Molecule, Assuming the Experience: The Pharmacology–Experience Asymmetry Framework for Psychedelic Research

Pobihuszka D

Europe PMC2026
ArticlePsychedelics

Designing evaluation infrastructure for psychedelic harm reduction at events: a methodological framework with formative mixed-methods field application

Veiseh N, Kment F, Acero V +10

Europe PMC2026
PreregistrationPsilocybin

Psilocybin in neurological disorders: a scoping review protocol

OSF2026